AGIOS PHARMACEUTICALS, INC. (AGIO) Free cash flow 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$377.3MFY2025 · since FY2016: $28.6M → -$377.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$377.3M | +3.6% |
| FY2024 | -$391.5M | -31.8% |
| FY2023 | -$297.1M | +5.5% |
| FY2022 | -$314.4M | +23.9% |
| FY2021 | -$413.1M | -35.5% |
| FY2020 | -$304.9M | +20.3% |
| FY2019 | -$382.6M | -22.9% |
| FY2018 | -$311.4M | -7.4% |
| FY2017 | -$289.9M | -1111.8% |
| FY2016 | $28.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice